In the De Vivo group, I am currently involved in a project in collaboration with the start-up IAMA therapeutics. My research focuses on the design, synthesis, and structure-activity-relationship studies of small molecules able to act selectively on a particular ion channel, highly expressed in brain, to develop new potential drugs for neurodevelopmental disorders treatment.
Research center
CHT@Erzelli
About
Colleagues of Molecular Modeling and Drug Discovery